Market Closed -
Nasdaq
04:00:00 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
0.0399
USD
|
-8.70%
|
|
-14.93%
|
-89.54%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
3.627
|
40.12
|
15.86
|
5.027
|
1.625
|
4.895
|
-
|
Enterprise Value (EV)
1 |
3.627
|
40.12
|
15.86
|
5.027
|
1.625
|
4.895
|
4.895
|
P/E ratio
|
-0.31
x
|
-1.55
x
|
-1.78
x
|
-0.18
x
|
-0.12
x
|
-0.44
x
|
-0.73
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.26
x
|
67.5
x
|
26.2
x
|
3.22
x
|
0.62
x
|
1.48
x
|
1.25
x
|
EV / Revenue
|
5.26
x
|
67.5
x
|
26.2
x
|
3.22
x
|
0.62
x
|
1.48
x
|
1.25
x
|
EV / EBITDA
|
-0.56
x
|
-4.76
x
|
-1.59
x
|
-0.48
x
|
-0.14
x
|
-0.36
x
|
-0.34
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.49
x
|
0.89
x
|
-
|
-
|
2
x
|
-0.57
x
|
Nbr of stocks (in thousands)
|
24.3
|
256
|
247
|
519
|
4,260
|
122,680
|
-
|
Reference price
2 |
149.0
|
157.0
|
64.19
|
9.680
|
0.3814
|
0.0399
|
0.0399
|
Announcement Date
|
3/26/20
|
3/22/21
|
3/25/22
|
3/29/23
|
3/27/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
0.689
|
0.594
|
0.606
|
1.561
|
2.627
|
3.302
|
3.906
|
EBITDA
1 |
-6.487
|
-8.421
|
-9.97
|
-10.37
|
-11.7
|
-13.41
|
-14.49
|
EBIT
1 |
-6.594
|
-8.504
|
-10.62
|
-11.34
|
-
|
-12.9
|
-12.1
|
Operating Margin
|
-957.04%
|
-1,431.65%
|
-1,752.48%
|
-726.14%
|
-
|
-390.61%
|
-309.82%
|
Earnings before Tax (EBT)
1 |
-4.797
|
-
|
-8.775
|
-12.04
|
-
|
-12.8
|
-12
|
Net income
1 |
-7.5
|
-16.59
|
-8.775
|
-16.49
|
-8.285
|
-14.06
|
-14.04
|
Net margin
|
-1,088.53%
|
-2,793.6%
|
-1,448.02%
|
-1,056.31%
|
-315.38%
|
-425.59%
|
-359.51%
|
EPS
2 |
-482.0
|
-101.0
|
-36.00
|
-54.67
|
-3.130
|
-0.0900
|
-0.0550
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/26/20
|
3/22/21
|
3/25/22
|
3/29/23
|
3/27/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
0.239
|
0.165
|
0.129
|
0.24
|
0.426
|
0.765
|
0.539
|
0.508
|
0.678
|
0.902
|
0.796
|
0.799
|
0.8145
|
0.893
|
0.786
|
EBITDA
1 |
-2.659
|
-2.394
|
-2.681
|
-2.58
|
-2.266
|
-2.6
|
-3.219
|
-3.056
|
-3.151
|
-2.275
|
-2.723
|
-3.028
|
-3.656
|
-4.005
|
-3.54
|
EBIT
1 |
-2.825
|
-2.591
|
-2.88
|
-2.783
|
-2.793
|
-2.881
|
-3.557
|
-3.464
|
-3.614
|
-
|
-3.2
|
-3.2
|
-3.2
|
-3.2
|
-3.2
|
Operating Margin
|
-1,182.01%
|
-1,570.3%
|
-2,232.56%
|
-1,159.58%
|
-655.63%
|
-376.6%
|
-659.93%
|
-681.89%
|
-533.04%
|
-
|
-402.01%
|
-400.5%
|
-392.88%
|
-358.34%
|
-407.12%
|
Earnings before Tax (EBT)
1 |
-2.343
|
-1.6
|
-2.845
|
-2.512
|
-2.724
|
-3.958
|
-0.293
|
-2.455
|
-3.19
|
-
|
-3.1
|
-3.2
|
-3.2
|
-3.2
|
-3.1
|
Net income
1 |
-2.343
|
-1.6
|
-2.845
|
-2.512
|
-2.724
|
-8.408
|
-0.293
|
-2.455
|
-3.19
|
-2.321
|
-3.131
|
-3.358
|
-3.642
|
-3.873
|
-3.1
|
Net margin
|
-980.33%
|
-969.7%
|
-2,205.43%
|
-1,046.67%
|
-639.44%
|
-1,099.08%
|
-54.36%
|
-483.27%
|
-470.5%
|
-257.32%
|
-393.34%
|
-420.34%
|
-447.21%
|
-433.71%
|
-394.4%
|
EPS
2 |
-9.000
|
-7.000
|
-12.00
|
-10.00
|
-11.00
|
-21.67
|
-0.1300
|
-0.6100
|
-0.8100
|
-0.0900
|
-0.0700
|
-0.0300
|
-0.0200
|
-0.0200
|
-0.0200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/12/21
|
3/25/22
|
5/13/22
|
8/12/22
|
11/14/22
|
3/29/23
|
5/15/23
|
8/8/23
|
11/14/23
|
3/27/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
105.0
|
71.70
|
-
|
-
|
0.0200
|
-0.0700
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.15
|
0.36
|
3.74
|
-
|
-
|
1.8
|
2.3
|
Capex / Sales
|
21.34%
|
60.61%
|
617%
|
-
|
-
|
54.5%
|
58.89%
|
Announcement Date
|
3/26/20
|
3/22/21
|
3/25/22
|
3/29/23
|
3/27/24
|
-
|
-
|
Last Close Price
0.0399
USD Average target price
1.5
USD Spread / Average Target +3,659.40% Consensus |
1st Jan change
|
Capi.
|
---|
| -89.54% | 4.89M | | +10.39% | 126B | | +2.52% | 8.97B | | +38.96% | 5.56B | | -17.50% | 4.99B | | +8.36% | 3.44B | | -8.84% | 2.8B | | -7.52% | 2.18B | | -3.00% | 2.16B | | -21.88% | 1.82B |
Medical Devices & Implants
|